NDC 60681-1704

Pleo Mucedo

Rhizopus Stolonifer

Pleo Mucedo is a Oral Liquid in the Human Otc Drug category. It is labeled and distributed by Sanum Kehlbeck Gmbh & Co. Kg. The primary component is Rhizopus Stolonifer.

Product ID60681-1704_32e6a14b-d9c7-4aee-9102-983aec01f7b6
NDC60681-1704
Product TypeHuman Otc Drug
Proprietary NamePleo Mucedo
Generic NameRhizopus Stolonifer
Dosage FormLiquid
Route of AdministrationORAL
Marketing Start Date1998-01-19
Marketing CategoryUNAPPROVED HOMEOPATHIC / UNAPPROVED HOMEOPATHIC
Labeler NameSanum Kehlbeck GmbH & Co. KG
Substance NameRHIZOPUS STOLONIFER
Active Ingredient Strength5 [hp_X]/mL
NDC Exclude FlagE
Listing Certified Through2017-12-31

Packaging

NDC 60681-1704-2

50 VIAL, GLASS in 1 CARTON (60681-1704-2) > 1 mL in 1 VIAL, GLASS
Marketing Start Date1998-01-19
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 60681-1704-1 [60681170401]

Pleo Mucedo LIQUID
Marketing CategoryUnapproved homeopathic
Product TypeHUMAN OTC DRUG
Marketing Start Date1998-01-19
Inactivation Date2019-11-13

NDC 60681-1704-2 [60681170402]

Pleo Mucedo LIQUID
Marketing CategoryUnapproved homeopathic
Product TypeHUMAN OTC DRUG
Marketing Start Date1998-01-19
Inactivation Date2019-11-13

Drug Details

Active Ingredients

IngredientStrength
RHIZOPUS STOLONIFER5 [hp_X]/mL

OpenFDA Data

SPL SET ID:6e083a0e-a6ea-4ff7-85d2-ce0aefc1280a
Manufacturer
UNII

NDC Crossover Matching brand name "Pleo Mucedo" or generic name "Rhizopus Stolonifer"

NDCBrand NameGeneric Name
60681-1701Pleo MucedoRHIZOPUS STOLONIFER
60681-1702Pleo Mucedorhizopus stolonifer
60681-1703Pleo Mucedorhizopus stolonifer
60681-1704Pleo Mucedorhizopus stolonifer
54575-217RHIZOPUS NIGRICANSrhizopus stolonifer
22840-2623Rhizopus stoloniferRhizopus stolonifer
22840-2624Rhizopus stoloniferRhizopus stolonifer
22840-2625Rhizopus stoloniferRhizopus stolonifer
22840-2627Rhizopus stoloniferRhizopus stolonifer
22840-5634Rhizopus stoloniferRhizopus stolonifer

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.